Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Miklós Bodor"'
Autor:
Sándor Halmi, Eszter Berta, Ágnes Diószegi, Lívia Sira, Péter Fülöp, Endre V. Nagy, Ferenc Győry, Zsolt Kanyári, Judit Tóth, Harjit Pal Bhattoa, Miklós Bodor
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
BackgroundInsulinomas are rare insulin-secreting neuroendocrine neoplasms of the pancreas. First-line treatment is the surgical removal of the tumor, however, the localization with standard imaging techniques is often challenging. With the help of se
Externí odkaz:
https://doaj.org/article/24c68db642ac4847b93d0321c2c62641
Autor:
Eszter Berta, Sándor Halmi, István Molnár, Dávid Hutkai, Sára Csiha, Harjit Pal Bhattoa, Hajnalka Lőrincz, Sándor Somodi, Mónika Katkó, Mariann Harangi, György Paragh, Endre V. Nagy, Miklós Bodor
Publikováno v:
Metabolites, Vol 14, Iss 10, p 565 (2024)
Background/Objectives: Fibroblast growth factor 21 (FGF21) is a hormonal regulator of lipid and glucose metabolism exerting protection against atherosclerosis by multiple actions on the blood vessels, liver, and adipose tissues. We aimed to investiga
Externí odkaz:
https://doaj.org/article/8ecbed7c95b64e63ab09e87007eb0ac2
Autor:
Balázs Ratku, Hajnalka Lőrincz, Sára Csiha, Veronika Sebestyén, Eszter Berta, Miklós Bodor, Endre V. Nagy, Zoltán Szabó, Mariann Harangi, Sándor Somodi
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
IntroductionAdult growth hormone deficiency (AGHD) is associated with a high prevalence of metabolic syndrome (MS), which contributes to the unfavorable cardiovascular risk profile in these patients. Insulin like growth factor-1 (IGF-1) is a widely u
Externí odkaz:
https://doaj.org/article/b8d908c1484f41ff9108f8ab56137316
Autor:
Miklós Bodor, Emese Mezősi
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/91d7051c7fdb4e2fa2895ecbe7fb98c1
Autor:
Sára Csiha, István Molnár, Sándor Halmi, Dávid Hutkai, Hajnalka Lőrincz, Sándor Somodi, Mónika Katkó, Mariann Harangi, György Paragh, Endre V. Nagy, Eszter Berta, Miklós Bodor
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
BackgroundAdvanced glycation end products (AGEs) are heterogenous group of irreversible chemical moieties originated from non-enzymatic glycation and oxidation of proteins, nucleic acids, and lipids. The engagement of AGEs with their chief cellular r
Externí odkaz:
https://doaj.org/article/cad884cd3a234e82a3ef85cfed3638fc
Autor:
Eszter Berta, Inez Lengyel, Sándor Halmi, Miklós Zrínyi, Annamária Erdei, Mariann Harangi, Dénes Páll, Endre V. Nagy, Miklós Bodor
Publikováno v:
Frontiers in Endocrinology, Vol 10 (2019)
Arterial hypertension represents a major global health concern; more than one fourth of the population is affected by high blood pressure. Albeit the underlying cause of the disease remains unclear in the vast majority of the cases, ~10% are of secon
Externí odkaz:
https://doaj.org/article/1e916f272e17445c864e4cd238b93432
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Eszter Berta, Inez Mercédesz Lengyel, László Hegedűs, Enrico Papini, Petros Perros, Roberto Negro, Roberto Attanasio, V. Endre Nagy, Miklós Bodor
Publikováno v:
Orvosi Hetilap. 163:463-472
Összefoglaló. Bevezetés: A pajzsmirigy-alulműködés gyakori betegség. Kezelésében a levotiroxin (LT4)-pótlás a szokásos eljárás, mely tabletta vagy gélkapszula formájában áll rendelkezésre Magyarországon. A nemzetközi trendeknek m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1dd51d3c344868abbb8a4961b30d4a8e
https://doi.org/10.1556/650.2022.32412
https://doi.org/10.1556/650.2022.32412
Autor:
Eszter, Berta, Noémi, Zsíros, Miklós, Bodor, István, Balogh, Hajnalka, Lőrincz, György, Paragh, Mariann, Harangi
Publikováno v:
Genes. 13(7)
Familial hypercholesterolemia (FH) is the most common monogenic metabolic disorder characterized by considerably elevated low-density lipoprotein cholesterol (LDL-C) levels leading to enhanced atherogenesis, early cardiovascular disease (CVD), and pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f3c136e51a07eb2a7f6818d9db335c79
https://pubmed.ncbi.nlm.nih.gov/35885941
https://pubmed.ncbi.nlm.nih.gov/35885941